查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853309

病毒学检体采集市场​​：依技术、检体类型、最终用户、疾病类型及通路划分－2025 - 2032年全球预测

Virology Specimen Collection Market by Technology, Sample Type, End User, Disease Type, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，病毒学检体体采集市场​​将成长至 193.2 亿美元，复合年增长率为 24.63%。

关键市场统计数据
基准年2024年 33.1亿美元
预计年份：2025年 41.3亿美元
预测年份 2032 193.2亿美元
复合年增长率（%） 24.63%

权威地阐述影响医疗保健系统中现代病毒学检体检体实务的技术、临床和操作驱动因素

病毒学检体采集系统支撑着诊断的准确性、检体的严谨性和公共卫生应对力。本导言概述了影响检体采集实务的核心要素，涵盖技术方法、检体类型、临床路径以及依赖检体完整性的最终使用者。在不断变化的法规和对快速可靠诊断日益增长的需求的推动下，检体采集方案如今已成为实验室能力、供应链韧性和临床工作流程三者交汇的关键环节。

本节概述了实验室和医疗机构在采集病毒学检体时面临的关键操作考量。它重点强调了分析前变数的重要性，从采集设备的选择到储存条件，以及这些因素如何影响下游检测的性能。此外，本节也将检体采集置于更广泛的系统层面驱动因素中，例如对感染监测、治疗监测和照护现场服务日益增长的需求。

读完本导言，读者将对影响检体采集实务的技术、物流和相关人员因素有清楚的了解。这项基础为后续章节中对技术模式、检体类型、终端用户动态、疾病重点领域和分发考虑的深入分析奠定了基础。

快速的技术进步、供应链现代化和监管调整如何重塑检体采集流程和临床检测预期

过去几年，检体采集领域发生了翻天覆地的变化，包括技术创新、营运流程重组和监管调整。新的检测方法和检体稳定化技术降低了分析前变异性，并实现了检测的广泛分散。同时，工作流程自动化和数位化样本追踪加强了样本采集与结果交付之间的联繫，提高了可追溯性并缩短了周转时间。这些变化重新定义了人们对检体品质和可用性的预期。

同时，快速诊断技术的兴起和分子序列测定的扩展改变了所需检体的类型以及检体收集和储存的要求。即时检测环境现在需要坚固耐用、易于使用且相容于多种检测方法的采集设备。因此，製造商和实验室优先考虑以使用者为中心的设计和互通性。监管机构也透过明确生物样本处理指南来回应，促进临床和研究环境中的标准化。

综合来看，这些变化带来了新的机会和压力：机会在于将检测范围扩大到服务不足的地区，并将诊断纳入常规护理路径；压力在于对供应链、员工培训和品质系统进行现代化改造，以满足人们对主导检体的决策日益增长的期望。

近期关税政策的变化如何促使检体采集供应链进行策略采购调整、供应商多元化和营运保障措施？

2025年关税政策的变化为检体采集耗材、仪器和辅助设备的筹资策略引入了新的变数。这些变化透过改变到岸成本和调整国内外供应商之间的比较优势，影响了诊断试剂生产商、实验室和经销商的采购成本核算。为此，采购团队审查了供应商多元化、库存缓衝和近岸外包等方案，以维持供应的连续性和价格竞争力。

关税波动对商业计划的累积影响是多方面的。实验室重新评估合同，将关税相关条款纳入其中，并提高订购弹性。製造商考虑其他零件供应商，并在条件允许的情况下实施本地组装，以减轻关税波动的影响。经销商调整定价框架和付款条件，以因应供应链复杂性的增加，同时与客户合作优化订单排序，减少缺货。在整个生态系统中，相关人员重视情境规划，以了解关税波动将如何影响前置作业时间和产品供应情况。

重要的是，这些调整优先考虑了维持检测可靠性和检体完整性。各机构在更换供应商和材料时采用了更严格的验证通讯协定，并增加对供应商品品管的投入，以确保关税压力带来的变化不会影响临床或研究结果。总体而言，这些因应措施表明，政策变化如何影响检体采集的技术、商业性和合规等各个方面。

从全面、细分的观点，分析技术模式、检体类型、最终用户、目标疾病和分销管道如何驱动业务优先事项。

深入的市场细分揭示了不同技术、检体类型、最终用户、疾病关注点和分销管道如何相互作用，从而定义检体收集领域中不同的需求和机会。依技术分析，CLIA 和 ELISA 等免疫检测对检体量和处理条件有特定要求，而包括数位 PCR 和即时PCR在内的 PCR 方法则需要严格的核酸储存和污染控制。快速检测，无论是比色法还是侧向层析法，都强调样本采集的便捷性和快速稳定性，而像次世代定序和 Sanger定序这样的测序方法则需要高品质的核酸提取和严格的监管链。

对样本类型的分析揭示了血液、拭子、组织和尿液样本不同的处理流程。拭子亚型，包括口腔拭子、鼻拭子和咽拭子，每种拭子都有不同的采集部位操作规程和运输介质需求；而组织样本，例如福马林固定组织和新鲜冷冻组织，则需要不同的储存方法和处理时间。临床和参考实验室需要标准化、高通量的样本采集流程；公立和私立医院需要在临床吞吐量和患者舒适度之间取得平衡；诊所和现场检测点优先考虑便携性和便利性；而学术和政府研究机构通常需要针对新型检测方法制定专门的通讯协定。

以疾病为导向的细分市场强调病原体特有的细微差别。例如，肝炎病毒变种、爱滋病毒、甲型和乙型流感病毒以及SARS-CoV-2病毒，各自都有其独特的采样窗口、生物安全预防措施和稳定性考量。此外，分销通路细分市场区分了直销、经销商网路和线上平台。本地和全国性经销商影响物流和前置作业时间，而企业网站和第三方电商平台则重塑采购行为和需求预测。整合这些层面的信息，有助于相关人员根据自身营运相关的技术和环境要求，调整产品设计、培训和供应策略。

美洲、欧洲、中东和非洲以及亚太地区的区域动态和基础设施现状

区域动态影响全球卫生系统检体采集的运作现况与策略重点。在美洲，已建立的实验室网路和完善的公共卫生基础设施促使人们投资于高通量采集途径、与集中式诊断平台的整合以及自动化，以支援广泛的监测和临床检测。该区域南北差异促使人们采用混合模式，将集中式采集能力与移动采集策略相结合，以涵盖偏远和医疗资源匮乏的社区。

在欧洲、中东和非洲，监管差异和基础设施不均导致检体采集实践呈现出多元化的特点，而这些特点强调适应性。中东和非洲部分地区优先考虑能力建设、低温运输韧性以及能够在资源受限的环境下可靠运作的分散式解决方案。这些区域差异促使各地在设备设计、人员编制模式和培训项目方面采取不同的方法。

亚太地区拥有多元化的医疗保健生态系统，从已开发国家高度集中的检测系统到新兴市场蓬勃发展的即时检测网络，不一而足。该地区兼具强大的製造能力和创新动力，催生了新型采集设备和可扩展的分销模式。这些区域特征共同影响采购偏好、检验要求以及新型检体采集方法的采用速度。

市场领导如何将产品创新、策略伙伴关係和供应链韧性结合，以建立端到端的检体采集解决方案和客户支援模式

主要企业在製定产品标准、推动设备设计创新以及塑造检体采集通路发挥着举足轻重的作用。市场领导企业正大力投资研发，以改进检体稳定化化学方法、提升采集设备的人体工学设计以及增强不同检测平台之间的兼容性。这些公司也致力于建立完善的品质系统和法规专业知识，以支持跨境商业化并加速临床实验室和即时检测机构的采用。

除了创新之外，策略伙伴关係和一体化服务模式正逐渐成为成功企业的标誌性特征。检测方法开发商、诊断实验室和物流供应商之间的合作，能够提供端到端的解决方案，从而降低推广门槛，并确保检体以可直接用于检测的状态送达。此外，投资于培训和客户支援的企业，能够帮助终端用户实施标准化的采集通讯协定，最大限度地减少分析前误差，从而实现显着的差异化优势。

竞争地位日益取决于供应链的韧性以及提供满足不同终端用户需求的模组化解决方案的能力。那些既能兼顾产品广度，又能集中投资于高影响力技术，并提供灵活销售方案的公司，往往能够获得医疗系统、研究机构和商业实验室的持续支持。

为产业领导者提供切实可行的策略蓝图，以协调设备创新、供应链韧性、监管参与和客户能力，从而成功完成检体采集。

产业领导者应采取整合策略，将产品创新与营运执行、监管前瞻性和供应链稳健性结合。优先考虑模组化仪器设计和跨检测相容性，可实现快速的临床和照护现场部署，并随着检测方法和测试平台的不断发展，降低验证负担。以使用者为中心的包装、清晰的标籤和培训材料的配对投资，将提高样本收集的准确性，减少分析前误差，并最终带来更好的后续结果。

在营运层面，各机构应实现供应商网路多元化，并考虑本地化生产或组装，以降低关税和物流风险，并维持品质监管。加强供应商资质资格确认流程并实施变更控制通讯协定，可确保材料替代不会影响检体完整性。同时，企业领导者必须积极与监管机构沟通，预判检体处理指南的变化，并简化新采集设备的核准。

最后，企业应拓展合作模式，将设备与培训、数位化检体追踪和物流服务捆绑在一起。透过提供整合解决方案，减轻实验室和诊所的实施负担，企业可以加速技术应用，建立更牢固的客户关係，并支持依赖可靠检体采集的公共卫生倡议。

严谨的混合方法研究途径，结合了相关人员访谈、技术文献综述和供应商检验，确保了对检体收集实践的可靠洞察。

本调查方法结合了定性和定量方法，对检体采集流程和市场动态进行了严谨的分析。主要研究包括对实验室主任、采购人员、临床医生和设备开发人员进行结构化访谈，以了解营运方面的见解和检验遇到的挑战。次要研究则整合了监管指南、技术标准和同行评审文献，以巩固主要研究的发现并检验观察到的趋势。

资料收集着重于跨资讯来源的一致性和三角验证，以识别因地区、最终用户和技术而异的实践。案例研究和供应商实质审查评估为供应链行为和产品检验选择提供了实际背景。此外，访谈记录的主题分析突显了反覆出现的痛点，包括分析前变异性、低温运输限制和训练缺口。

最后，研究结果经过内部同侪审查和调查方法检验，以确保其可靠性。这包括将程序描述与已发布的专业技术标准交叉比对，并在出现复杂或相互矛盾的资讯时向专家寻求澄清。总体而言，该方法兼顾了领域层面的细微差别和系统检验，从而为可操作的建议提供基础。

一份全面的结论总结，重点强调了综合检体采集实践、相关人员合作以及为保持诊断信心和公共卫生影响而采取的营运重点。

总之，检体体采集对于诊断准确性、研究有效性和公共卫生应对至关重要。技术进步、法规演变和区域基础设施差异已全面重塑了检体的采集、储存和运输方式。相关人员，最能提供可靠的、主导检体的检测结果。

本文所展示的整合凸显了整合解决方案的必要性，这些解决方案能够减少分析前变异性，并支援在临床、照护现场和研究环境中进行可扩展的检测。透过专注于互通性、培训和分发灵活性，各机构可以降低营运风险，并提高其诊断和监测计画的有效性。展望未来，设备製造商、实验室、医疗服务提供者和政策制定者之间需要持续合作，以确保检体采集实践与诊断创新同步发展。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 整合机器人样本处理平台可提高病毒检体采集的通量并降低污染风险。
  • 推出一款可携式即时检测PCR分析仪，用于在护理点分散检测流感和SARS-CoV-2
  • 引入远端医疗指导的自采集鼻拭子试剂套件，以扩大远距病毒检测服务的覆盖范围。
  • 开发一种温度稳定的病毒转运培养基配方，可延长保质期并最大限度地减少对低温运输的依赖。
  • 新兴的干泡沫拭子技术可用于资源匮乏地区呼吸道病毒检体的常温储存和运输
  • 在病毒学实验室中实施基于区块链的数位样本追踪系统，以加强监管链完整性和资料安全性
  • 扩大高通量自动化核酸萃取设备的生产规模，以满足呼吸道病毒爆发期间的需求激增
  • 将多重分子检测板整合到常规检测通讯协定中，推动了标准化检体采集工作流程的需求。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按技术分類的病毒学检体体采集市场

  • 免疫检测
    • CLIA
    • ELISA
  • PCR
    • 数位PCR
    • 即时PCR
  • 快速检测
    • 比色测试
    • 侧向流
  • 定序
    • 次世代定序
    • 桑格定序

9. 依样本类型分類的病毒学检检体采集市场

  • 血
  • 棉花棒
    • 口腔拭子
    • 鼻拭子
    • 咽拭子
  • 组织
    • 福马林固定组织
    • 新鲜冷冻组织
  • 尿

第十章 依最终使用者分類的病毒学检体采集市场

  • 诊断实验室
    • 临床实验室
    • 参考实验室
  • 医院
    • 私立医院
    • 公立医院
  • 照护现场
    • 诊所
    • 现场测试场地
  • 研究机构
    • 学术机构
    • 政府机构

第十一章 依疾病类型分類的病毒学检检体采集市场

  • 肝炎
    • 甲型肝炎
    • B型肝炎
    • C型肝炎
  • HIV
  • 流感
    • 甲型流感
    • 乙型流感
  • SARS-CoV-2

第十二章 病毒学检检体采集市场​​（依通路划分）

  • 直销
  • 经销商
    • 当地经销商
    • 全国经销商
  • 线上管道
    • 公司网站
    • 第三方电子商务

13. 各地区病毒学检体体采集市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 病毒学检体采集市场​​（依检体划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国病毒学检体体采集市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson and Company
    • Copan Diagnostics, Inc.
    • bioMerieux SA
    • QIAGEN NV
    • Puritan Medical Products Company LLC
    • Sarstedt AG & Co. KG
    • Greiner Bio-One International GmbH
    • Merck KGaA
    • Cardinal Health, Inc.
Product Code: MRR-8201ABF20F0B

The Virology Specimen Collection Market is projected to grow by USD 19.32 billion at a CAGR of 24.63% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.31 billion
Estimated Year [2025] USD 4.13 billion
Forecast Year [2032] USD 19.32 billion
CAGR (%) 24.63%

An authoritative orientation to the technical, clinical, and operational drivers shaping modern virology specimen collection practices in healthcare systems

The landscape of virology specimen collection underpins diagnostic accuracy, research fidelity, and public health responsiveness. This introduction frames the core elements that influence specimen collection practices, encompassing technological approaches, specimen types, clinical pathways, and the end users that rely on robust sample integrity. Against a backdrop of regulatory evolution and heightened demand for rapid, reliable diagnostics, specimen collection protocols now sit at the intersection of laboratory capability, supply chain resilience, and clinical workflows.

This section outlines the major operational considerations that laboratories and healthcare providers face when collecting virology specimens. It emphasizes the importance of pre-analytical variables - from collection device selection to storage conditions - and highlights how these factors cascade into downstream assay performance. In addition, the introduction situates specimen collection within broader system-level drivers, including infection surveillance, therapeutic monitoring, and the scaling needs of point-of-care services.

By the end of this introduction, readers will have a clear orientation to the technical, logistical, and stakeholder forces shaping specimen collection practices. This foundation sets the stage for deeper analysis across technology modalities, sample types, end-user dynamics, disease focus areas, and distribution considerations that follow in subsequent sections.

How rapid technological advances, supply chain modernization, and regulatory alignment are reshaping specimen collection workflows and clinical testing expectations

The last several years have produced transformative shifts across the specimen collection landscape, spanning technological innovation, operational redesign, and regulatory adaptation. New assay formats and sample stabilization chemistries have reduced pre-analytical variability, enabling broader decentralization of testing. At the same time, workflow automation and digital sample tracking have tightened the link between collection and result delivery, improving traceability and shortening turnaround times. These changes have redefined expectations for specimen quality and availability.

Concurrently, the rise of rapid diagnostic modalities and the expansion of molecular sequencing have changed the kinds of specimens required and the conditions under which they must be collected and preserved. Point-of-care settings now demand collection devices that are robust, easy to use, and compatible with a range of assays. As a result, manufacturers and laboratories have prioritized user-centered design and interoperability. Regulatory bodies have also responded by clarifying guidance on biospecimen handling, which in turn has driven standardization across clinical and research environments.

Taken together, these shifts have created new opportunities and pressures: opportunities to extend testing to underserved settings and to integrate diagnostics into routine care pathways, and pressures to modernize supply chains, staff training, and quality systems to meet elevated expectations for specimen-driven decision making.

How recent tariff policy shifts have prompted strategic sourcing adaptations, supplier diversification, and operational safeguards across specimen collection supply chains

Tariff policy changes in 2025 introduced new variables into procurement strategies for specimen collection consumables, devices, and ancillary equipment. These changes influenced the sourcing calculus for diagnostic manufacturers, laboratories, and distributors by altering landed costs and shifting comparative advantages among domestic and international suppliers. In response, procurement teams reassessed supplier diversification, inventory buffering, and nearshoring options to preserve continuity of supply and maintain competitive pricing structures.

The cumulative effect on operational planning has been multifaceted. Laboratories re-evaluated their contracts to incorporate tariff-related clauses and to build flexibility into purchase orders. Manufacturers explored alternative component suppliers and, where feasible, localized assembly to mitigate exposure to variable duties. Distributors adjusted pricing frameworks and payment terms to reflect increased supply chain complexity, while also working with clients to optimize order cadence and reduce stockouts. Across the ecosystem, stakeholders emphasized scenario planning to understand how tariff volatility could affect lead times and product availability.

Importantly, these adjustments prioritized maintaining assay reliability and specimen integrity. Organizations adopted more rigorous validation protocols when transitioning between suppliers or materials and invested in supplier quality management to ensure that changes driven by tariff pressures did not compromise clinical or research outcomes. The overall response demonstrates how policy shifts can ripple across technical, commercial, and compliance dimensions of specimen collection.

Comprehensive segmentation-driven perspective on how technology modalities, specimen types, end users, disease focus, and distribution channels jointly determine operational priorities

Insightful segmentation reveals how different technologies, specimen types, end users, disease focuses, and distribution channels interact to define distinct needs and opportunities across the specimen collection domain. When analyzed by technology, immunoassays such as CLIA and ELISA present requirements for specific sample volumes and handling conditions, while PCR approaches including digital PCR and real-time PCR demand stringent nucleic acid preservation and contamination controls. Rapid tests, whether colorimetric assays or lateral flow formats, emphasize ease of collection and rapid stability, and sequencing modalities like next-generation sequencing and Sanger sequencing require high-quality nucleic acid extraction and chain-of-custody considerations.

Examining sample types shows divergent workflows for blood, swabs, tissue, and urine; swab subtypes including buccal, nasal, and throat collections each introduce distinct collection site protocols and transport media considerations, while tissue options such as formalin-fixed and fresh frozen formats require divergent preservation methods and processing timelines. End-user segmentation highlights operational contrasts among diagnostic laboratories, hospitals, point-of-care venues, and research institutes; clinical and reference laboratories demand standardized, high-throughput collection pipelines, private and public hospitals balance clinical throughput with patient comfort, clinics and field testing sites prioritize portability and simplicity, and academic or government research institutes often require specialized protocols for novel assays.

Disease-oriented segmentation draws attention to pathogen-specific nuances: hepatitis variants, HIV, influenza A and B, and SARS-CoV-2 each impose unique sampling windows, biosafety precautions, and stability concerns. Finally, distribution channel segmentation differentiates direct sales, distributor networks, and online platforms; local and national distributors influence logistics and lead times, while company websites and third-party e-commerce platforms reshape procurement behaviors and demand forecasting. Synthesizing these layers enables stakeholders to tailor product design, training, and supply strategies to the combination of technological and contextual requirements relevant to their operations.

Regional dynamics and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that inform tailored specimen collection strategies and investments

Regional dynamics shape both operational realities and strategic priorities for specimen collection across global health systems. In the Americas, established laboratory networks and expansive public health infrastructure emphasize high-throughput collection pathways, integration with centralized diagnostic platforms, and investment in automation that supports broad surveillance and clinical testing. North-south differences within the region encourage hybrid approaches that combine centralized capacity with mobile collection strategies to reach remote or underserved communities.

Across Europe, the Middle East and Africa, regulatory heterogeneity and variable infrastructure create a mosaic of specimen collection practices that emphasize adaptability. West European countries often focus on harmonized standards and interoperability, while parts of the Middle East and Africa prioritize capacity building, cold chain resiliency, and decentralized solutions that can operate reliably in constrained settings. These regional contrasts drive differentiated approaches to device design, staffing models, and training programs.

In Asia-Pacific, diverse healthcare ecosystems range from highly centralized laboratory systems in advanced economies to rapidly growing point-of-care networks in emerging markets. The region combines strong manufacturing capabilities with an appetite for innovation, producing both novel collection devices and scalable distribution models. Collectively, these regional characteristics influence procurement preferences, validation requirements, and the pace at which new specimen collection practices are adopted.

How market leaders combine product innovation, strategic partnerships, and supply chain resilience to establish end-to-end specimen collection solutions and customer support models

Leading companies play pivotal roles in defining product standards, driving innovation in device design, and shaping distribution channels for specimen collection. Market leaders have concentrated investments in research and development to improve sample stabilization chemistries, ergonomics of collection devices, and compatibility across assay platforms. These firms also focus on building robust quality systems and regulatory expertise to support cross-border commercialization and to accelerate adoption among clinical laboratories and point-of-care providers.

Beyond innovation, strategic partnerships and integrated service models have emerged as defining behaviors among successful companies. Collaborations with assay developers, diagnostics labs, and logistics providers enable end-to-end solutions that reduce barriers to adoption and ensure specimens arrive in a test-ready state. Additionally, companies that invest in training and customer support create meaningful differentiation by helping end users implement standardized collection protocols and minimize pre-analytical errors.

Competitive positioning is increasingly informed by supply chain resilience and the ability to offer modular solutions that meet diverse end-user needs. Firms that balance product breadth with focused investments in high-impact technologies and that offer flexible distribution options tend to capture sustained engagement from health systems, research institutes, and commercial laboratories.

Actionable strategic roadmap for industry leaders to synchronize device innovation, supply chain resilience, regulatory engagement, and customer enablement for specimen collection success

Industry leaders should adopt an integrated strategy that aligns product innovation with operational execution, regulatory foresight, and supply chain robustness. Prioritizing modular device design and compatibility across assay types will enable faster uptake in clinical and point-of-care settings and reduce validation burdens when assays or testing platforms evolve. Complementary investments in user-centric packaging, clear labeling, and training materials will improve collection fidelity and reduce pre-analytical errors, delivering better downstream outcomes.

Operationally, organizations should diversify supplier networks and consider regional manufacturing or assembly to mitigate tariff and logistics risks while maintaining quality oversight. Strengthening supplier qualification processes and implementing change control protocols will ensure that material substitutions do not degrade specimen integrity. Simultaneously, leaders must engage proactively with regulatory authorities to anticipate changes in specimen handling guidance and to streamline approvals for novel collection devices.

Finally, companies should expand collaborative models that bundle devices with training, digital sample tracking, and logistics services. By offering integrated solutions that lower the implementation burden for laboratories and clinics, organizations can accelerate adoption, create stickier customer relationships, and support public health initiatives that depend on reliable specimen collection.

A rigorous mixed-methods research approach combining stakeholder interviews, technical literature synthesis, and supplier validation to ensure reliable insights into specimen collection practices

The research methodology integrates qualitative and quantitative approaches to produce a rigorous analysis of specimen collection practices and market dynamics. Primary research includes structured interviews with laboratory directors, procurement professionals, clinicians, and device developers to capture operational insights and validation challenges. Secondary research synthesizes regulatory guidance, technical standards, and peer-reviewed literature to contextualize primary findings and to validate observed trends.

Data collection emphasized triangulation across sources to confirm consistency and to identify divergent practices by region, end user, and technology. Case studies and vendor due-diligence evaluations provided practical context for supply chain behaviors and product validation choices. In addition, thematic analysis of interview transcripts highlighted recurring pain points such as pre-analytical variability, cold chain constraints, and training gaps.

Finally, findings were subjected to internal peer review and methodological checks to ensure reliability. This included cross-referencing procedural descriptions with published technical standards and seeking clarification from subject matter experts when complex or conflicting information arose. The overall approach balances field-level nuance with systematic validation to inform practical recommendations.

Concluding synthesis emphasizing integrated specimen collection practices, cross-stakeholder collaboration, and operational priorities to sustain diagnostic reliability and public health impact

In conclusion, specimen collection lies at the center of diagnostic accuracy, research validity, and public health responsiveness. Technological advances, regulatory evolution, and regional infrastructure differences have collectively reshaped how specimens are collected, preserved, and transported. Stakeholders that align product design with end-user workflows, invest in supply chain resilience, and proactively engage with regulatory expectations will be best positioned to deliver reliable specimen-driven outcomes.

The synthesis presented here emphasizes the need for integrated solutions that reduce pre-analytical variability and support scalable testing across clinical, point-of-care, and research environments. By focusing on interoperability, training, and distribution flexibility, organizations can mitigate operational risks and enhance the impact of diagnostic and surveillance programs. The path forward requires ongoing collaboration among device makers, laboratories, healthcare providers, and policy makers to ensure specimen collection practices evolve in step with diagnostic innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of robotics-driven sample processing platforms to increase throughput and reduce contamination risk in virus specimen collection
  • 5.2. Adoption of portable point-of-care PCR analyzers for decentralized detection of influenza and SARS-CoV-2 at patient sites
  • 5.3. Implementation of telehealth-guided self-collection nasal swab kits to expand access to remote virology testing services
  • 5.4. Development of temperature-stable viral transport media formulations enabling extended shelf life and minimal cold chain reliance
  • 5.5. Emergence of dry foam swab technologies for ambient-temperature storage and transport of respiratory virus specimens in resource-limited regions
  • 5.6. Deployment of blockchain-enabled digital sample tracking systems to enhance chain-of-custody integrity and data security in virology labs
  • 5.7. Scaling up of high-throughput automated nucleic acid extraction instruments to meet surge demands during respiratory virus outbreaks
  • 5.8. Integration of multiplex molecular assay panels in routine testing protocols driving need for standardized specimen collection workflows

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Virology Specimen Collection Market, by Technology

  • 8.1. Immunoassay
    • 8.1.1. CLIA
    • 8.1.2. ELISA
  • 8.2. PCR
    • 8.2.1. Digital PCR
    • 8.2.2. Real-Time PCR
  • 8.3. Rapid Test
    • 8.3.1. Colorimetric Test
    • 8.3.2. Lateral Flow
  • 8.4. Sequencing
    • 8.4.1. Next-Generation Sequencing
    • 8.4.2. Sanger Sequencing

9. Virology Specimen Collection Market, by Sample Type

  • 9.1. Blood
  • 9.2. Swab
    • 9.2.1. Buccal Swab
    • 9.2.2. Nasal Swab
    • 9.2.3. Throat Swab
  • 9.3. Tissue
    • 9.3.1. Formalin Fixed Tissue
    • 9.3.2. Fresh Frozen Tissue
  • 9.4. Urine

10. Virology Specimen Collection Market, by End User

  • 10.1. Diagnostic Laboratories
    • 10.1.1. Clinical Laboratories
    • 10.1.2. Reference Laboratories
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Point Of Care
    • 10.3.1. Clinics
    • 10.3.2. Field Testing Sites
  • 10.4. Research Institutes
    • 10.4.1. Academic Institutes
    • 10.4.2. Government Institutes

11. Virology Specimen Collection Market, by Disease Type

  • 11.1. Hepatitis
    • 11.1.1. Hepatitis A
    • 11.1.2. Hepatitis B
    • 11.1.3. Hepatitis C
  • 11.2. HIV
  • 11.3. Influenza
    • 11.3.1. Influenza A
    • 11.3.2. Influenza B
  • 11.4. SARS-CoV-2

12. Virology Specimen Collection Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
    • 12.2.1. Local Distributors
    • 12.2.2. National Distributors
  • 12.3. Online Channels
    • 12.3.1. Company Website
    • 12.3.2. Third-Party E-Commerce

13. Virology Specimen Collection Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Virology Specimen Collection Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Virology Specimen Collection Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Becton, Dickinson and Company
    • 16.3.3. Copan Diagnostics, Inc.
    • 16.3.4. bioMerieux SA
    • 16.3.5. QIAGEN N.V.
    • 16.3.6. Puritan Medical Products Company LLC
    • 16.3.7. Sarstedt AG & Co. KG
    • 16.3.8. Greiner Bio-One International GmbH
    • 16.3.9. Merck KGaA
    • 16.3.10. Cardinal Health, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VIROLOGY SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VIROLOGY SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VIROLOGY SPECIMEN COLLECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIS